Compound Detail
CHEMBL4863676
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C/C1=C\CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)/C(=C\c3ccc4nc[nH]c(=O)c4c3)[C@@H]2CC1
Basic Information
| ChEMBL ID | CHEMBL4863676 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VQILEQMBHYYXMA-VLUXSWMESA-N |
7
Targets
7
Activities
1
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
392.5
MW (Da)
3.53
ALogP
5
HBA
1
HBD
84.6
PSA (Ų)
0.35
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 4.61
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| U2OS CHEMBL615023 | IC50 | 4.61 | 4.61 | 24640.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 4.54 | 4.54 | 28640.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 4.48 | 4.48 | 32890.0 | 1 |
| A549 CHEMBL392 | IC50 | 4.47 | 4.47 | 33540.0 | 1 |
| SW480 CHEMBL612544 | IC50 | 4.47 | 4.47 | 33960.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.26 | 4.26 | 55120.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.06 | 4.06 | 86650.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| U2OS | IC50 | = | 24640.0 | nM | 4.61 | Cytotoxicity against human U2OS cells assessed as reduction in cell viability in... | 34847663 |
| HT-29 | IC50 | = | 28640.0 | nM | 4.54 | Cytotoxicity against human HT-29 cells assessed as reduction in cell viability i... | 34847663 |
| HCT-116 | IC50 | = | 32890.0 | nM | 4.48 | Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability... | 34847663 |
| SW480 | IC50 | = | 33960.0 | nM | 4.47 | Cytotoxicity against human SW480 cells assessed as reduction in cell viability i... | 34847663 |
| A549 | IC50 | = | 33540.0 | nM | 4.47 | Cytotoxicity against human A549 cells assessed as reduction in cell viability in... | 34847663 |
| MDA-MB-231 | IC50 | = | 55120.0 | nM | 4.26 | Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viabil... | 34847663 |
| HepG2 | IC50 | = | 86650.0 | nM | 4.06 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i... | 34847663 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34847663 | 10.1021/acs.jmedchem.1c01380 | HT-29 | 1 |
| 34847663 | 10.1021/acs.jmedchem.1c01380 | SW480 | 1 |
| 34847663 | 10.1021/acs.jmedchem.1c01380 | HCT-116 | 1 |
| 34847663 | 10.1021/acs.jmedchem.1c01380 | A549 | 1 |
| 34847663 | 10.1021/acs.jmedchem.1c01380 | U2OS | 1 |
| 34847663 | 10.1021/acs.jmedchem.1c01380 | HepG2 | 1 |
| 34847663 | 10.1021/acs.jmedchem.1c01380 | MDA-MB-231 | 1 |
Data from ChEMBL 36 via Core Engine